Early microbiological response to linezolid vs vancomycin in ventilator-associated pneumonia due to methicillin-resistant Staphylococcus aureus.
about
Methicillin-resistant Staphylococcus aureus nosocomial pneumonia: role of linezolid in the People's Republic of ChinaEfficacy and safety of linezolid in liver transplant patients.A comparative evaluation of adverse platelet outcomes among Veterans' Affairs patients receiving linezolid or vancomycin.Treatment of hospital-acquired pneumonia with linezolid or vancomycin: a systematic review and meta-analysis.Linezolid versus vancomycin for the treatment of suspected methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a systematic review employing meta-analysis.Vancomycin-associated nephrotoxicity: grave concern or death by character assassination?MRSA: treating people with infection.Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children.An economic model to compare linezolid and vancomycin for the treatment of confirmed methicillin-resistant Staphylococcus aureus nosocomial pneumonia in Germany.Modeling the economic impact of linezolid versus vancomycin in confirmed nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus.The efficacy and safety of linezolid and glycopeptides in the treatment of Staphylococcus aureus infectionsLinezolid vs glycopeptide antibiotics for the treatment of suspected methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a meta-analysis of randomized controlled trials.Penetration of vancomycin into epithelial lining fluid in healthy volunteers.Comparative-effectiveness of vancomycin and linezolid as part of guideline-recommended empiric therapy for healthcare-associated pneumonia.Comparative in vivo efficacies of epithelial lining fluid exposures of tedizolid, linezolid, and vancomycin for methicillin-resistant Staphylococcus aureus in a mouse pneumonia model.Predicting risk for death from MRSA bacteremia.Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society.A trial of discontinuation of empiric vancomycin therapy in patients with suspected methicillin-resistant Staphylococcus aureus health care-associated pneumonia.Antimicrobial resistance: Not community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA)! A clinician's guide to community MRSA - its evolving antimicrobial resistance and implications for therapy.Nosocomial methicillin-resistant Staphylococcus aureus (MRSA) pneumonia: linezolid or vancomycin? - Comparison of pharmacology and clinical efficacy.An evidence-based review of linezolid for the treatment of methicillin-resistant Staphylococcus aureus (MRSA): place in therapy.Linezolid versus vancomycin or teicoplanin for nosocomial pneumonia: meta-analysis of randomised controlled trials.Assessment of bias in outcomes reported in trials on pneumonia: a systematic review.Participation of elderly adults in randomized controlled trials addressing antibiotic treatment of pneumonia.A 2015 Update on Ventilator-Associated Pneumonia: New Insights on Its Prevention, Diagnosis, and Treatment.MRSA in Croatia: prevalence and management.Linezolid: a promising option in the treatment of Gram-positives.α-Hemolysin activity of methicillin-susceptible Staphylococcus aureus predicts ventilator-associated pneumonia.Comparative effectiveness of linezolid and vancomycin among a national veterans affairs cohort with methicillin-resistant Staphylococcus aureus pneumonia.Meta-analysis of randomized controlled trials of vancomycin for the treatment of patients with gram-positive infections: focus on the study designMethicillin-resistant Staphylococcus aureus guidelines: a myriad of open questions.Relationship between the MIC of vancomycin and clinical outcome in patients with MRSA nosocomial pneumonia.Affect of linezolid in ventilator-associated pneumonia caused by MRSA.
P2860
Q26749179-E9D2ADA9-6F75-478D-BFE6-E7AA792C7ABCQ33394330-B4C45C56-8A81-43B2-886A-EA8E97DE7419Q33398776-EF5A66DC-FFCA-43BE-AC76-2FCC6A394FFEQ33410942-8FA1DDE1-93D7-4CDE-9B94-AC261C3ECBE8Q33418451-D49E3061-159A-4240-A7C8-8A61F4C5D9D3Q33617737-3DE0AEBD-C53B-4D8B-AC77-BBA9B6344604Q33850476-36439487-BA42-4427-9DF0-2907D1334E84Q34157657-47EF911F-666B-4094-B698-D1AC9C0DFECEQ34434763-90F0588C-BBD2-423E-98F4-E9DF03F73E1FQ34452009-34037507-4947-40DD-876B-0AFB9BB75795Q34618696-2C6CFF13-FD08-44A3-887B-00DBA62511AFQ34923394-6E1F2FD2-DA5D-42ED-8389-42CEA56D85FDQ35598408-5B259B41-4E33-4B27-9A5C-569DD8D93542Q35780121-0CE4EEF7-FDD6-45F4-A79B-CB3CA1940C6EQ35941253-775F3E74-A3AB-45CA-82FE-BD5B3EAA5183Q36037687-D32374B3-FE21-4FBA-87A5-FB535CFC05EDQ36078359-A25C4D75-246A-458B-B6BB-35AF64A848D0Q36666990-367C9E40-9E99-4CE0-B8BC-BA2B59369620Q37819539-4C9793CC-5160-42DF-90BF-960684EAB47EQ37821604-D91EA11B-C53F-4FCB-B34D-4FEDEFAEE3CEQ38070154-EBF7B477-951A-4D6F-AEBC-F322317962A2Q38097374-C0B20CF3-0A1B-4199-875B-97FFA8CA01CAQ38172440-CD4285C3-5E8C-46D6-84C3-72425524BC38Q38358209-0F2FB4BD-67AE-4D99-A9C3-F95583A07E2BQ38538710-910636B8-3F7C-49EB-8824-D5CF1E5F8788Q38631043-A799CB57-3697-4E85-9EC7-BDDA757F2405Q39044932-C7EBCD0C-BEFC-41EE-B29D-28E52032F1F5Q41706378-8E0B89A3-DDD0-4DC0-9179-6B5164367A7EQ42233083-8B33AD49-7034-413A-B453-A3CD9A5CA736Q42544277-92AE5266-861D-43EB-B6FD-B411EFD39CD5Q42749222-F83C6638-E485-498C-B188-6E2EC28DFFB3Q45279504-EC7CC6CF-9494-4B17-8170-F693D90BBA12Q46103421-FD386D76-C7E7-4C33-AFE0-22A083F66E38
P2860
Early microbiological response to linezolid vs vancomycin in ventilator-associated pneumonia due to methicillin-resistant Staphylococcus aureus.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Early microbiological response ...... sistant Staphylococcus aureus.
@en
type
label
Early microbiological response ...... sistant Staphylococcus aureus.
@en
prefLabel
Early microbiological response ...... sistant Staphylococcus aureus.
@en
P2093
P921
P356
P1433
P1476
Early microbiological response ...... sistant Staphylococcus aureus.
@en
P2093
Addison K May
Helen Bhattacharyya
Kenneth V Leeper
Meryl H Mendelson
Michael S Somero
Timothy C Fabian
P304
P356
10.1378/CHEST.08-0011
P407
P577
2008-08-21T00:00:00Z